openPR Logo
Press release

Investigation announced for Long-Term Investors who lost money with shares of Veradigm Inc. (NASDAQ: MDRX)

An investigation on behalf of current long term investors in Veradigm Inc. (NASDAQ: MDRX) shares.

An investigation on behalf of current long term investors in Veradigm Inc. (NASDAQ: MDRX) shares.

An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Veradigm Inc..

Investors who are current long term investors in Veradigm Inc. (NASDAQ: MDRX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: MDRX stocks follows a lawsuit filed against Veradigm Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: MDRX stocks, concerns whether certain Veradigm Inc directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Northern District of Illinois the plaintiff alleges that, the defendants made false and/or misleading statements and/or failed to disclose that: (i) Veradigm had overstated its historical revenues by at least $20 million; (ii) Veradigm had artificially inflated its revenue by recording duplicate transactions, among other things, over a more than two-year period; (iii) Veradigm had artificially inflated its earnings and margins and materially misrepresented demand for Veradigm's products and services; (iv) Veradigm had failed to maintain effective internal controls over its financial reporting; and (v) Veradigm had failed to comply with Generally Accepted Accounting Principles regarding appropriate revenue recognition practices.

Those who purchased shares of Veradigm Inc. (NASDAQ: MDRX) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investors who lost money with shares of Veradigm Inc. (NASDAQ: MDRX) here

News-ID: 3465065 • Views:

More Releases from Shareholders Foundation, Inc.

Novo Nordisk A/S (NYSE: NVO) Long Term Investor Alert: Investigation of potential Wrongdoing
Novo Nordisk A/S (NYSE: NVO) Long Term Investor Alert: Investigation of potentia …
An investigation on behalf of current long-term investors in shares of Novo Nordisk A/S (NYSE: NVO) concerning potential breaches of fiduciary duties by certain directors and officers was announced. Investors who are current long term investors in Novo Nordisk A/S (NYSE: NVO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for long term investors in
Lawsuit filed for Investors who lost money with shares of Fortinet, Inc. (NASDAQ: FTNT)
Lawsuit filed for Investors who lost money with shares of Fortinet, Inc. (NASDAQ …
An investor, who purchased shares of Fortinet, Inc. (NASDAQ: FTNT), filed a lawsuit over alleged violations of Federal Securities Laws by Fortinet, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Fortinet, Inc. (NASDAQ: FTNT) have certain options and for certain investors are short and strict deadlines running. Deadline: November 21, 2025. NASDAQ: FTNT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
CTO Realty Growth, Inc. (NYSE: CTO) Investor Alert: Deadline in Lawsuit on October 07, 2025
CTO Realty Growth, Inc. (NYSE: CTO) Investor Alert: Deadline in Lawsuit on Octob …
A deadline is coming up on October 07, 2025in the lawsuit filed for certain investors of CTO Realty Growth, Inc. (NYSE: CTO) over alleged securities laws violations by CTO Realty Growth, Inc. Investors who purchased shares of CTO Realty Growth, Inc. (NYSE: CTO) have certain options and there are strict and short deadlines running. Deadline: October 07, 2025. CTO Realty Growth, Inc. (NYSE: CTO) stockholders should contact the Shareholders Foundation at
Alert: Lawsuit filed for Investors who lost money with shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR)
Alert: Lawsuit filed for Investors who lost money with shares of Jasper Therapeu …
An investor, who purchased shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR), filed a lawsuit over alleged violations of Federal Securities Laws by Jasper Therapeutics, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 18, 2025. NASDAQ: JSPR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com

All 5 Releases


More Releases for Veradigm

Healthcare Information Exchange Market Is Booming Worldwide | Epic Systems Corpo …
The qualitative latest Research report (2025-2032) on the Healthcare Information Exchange Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133623 Focused on growth
EHR Software Market May Set New Growth Story | CureMD Corporation, Athenahealth, …
HTF MI recently introduced Global EHR Software Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2025-2032). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence. 𝐌𝐚𝐣𝐨𝐫 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 in EHR Software Market are: Allscripts healthcare solutions Inc. (United States), Cerner Corporation (United States), Computer programs and systems Inc. (United
Revenue Cycle Management Industry May See a Big Move | Epic Systems, GeBBs, Vera …
Data Insights Market published a new research publication on "Revenue Cycle Management Industry Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Revenue Cycle Management Industry was mainly driven by the increasing R&D spending across the world. Some of the key players
Revenue Cycle Management Market Next Big Thing | Major Giants- McKesson, Epic Sy …
Archive Market Research published a new research publication on "Revenue Cycle Management Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Revenue Cycle Management market was mainly driven by the increasing R&D spending across the world. Some of the key players
Lawsuit filed for certain investors who lost money with shares of Veradigm Inc. …
An investor, who purchased shares of Veradigm Inc. (NASDAQ: MDRX), filed a lawsuit over alleged violations of Federal Securities Laws by Veradigm Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Veradigm Inc. (NASDAQ: MDRX) have certain options and for certain investors are short and strict deadlines running. Deadline: January 22, 2024. NASDAQ: MDRX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
Investigation announced for Investors in Veradigm Inc. (NASDAQ: MDRX) over poten …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Veradigm Inc. Investors who purchased shares of Veradigm Inc. (NASDAQ: MDRX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Veradigm Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders. Chicago, IL based Veradigm